{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:10Z","timestamp":1786986850213,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.clinthera.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T19:16:19Z","timestamp":1494011779000},"page":"1171-1181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens"],"prefix":"10.1016","volume":"39","author":[{"given":"Janthima","family":"Methaneethorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.04.005_bib1","series-title":"Basic Clinical Pharmacokinetics","author":"Winter","year":"2010"},{"key":"10.1016\/j.clinthera.2017.04.005_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: a simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2017.04.005_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4088\/PCC.v01n0304","article-title":"Anticonvulsant use in the treatment of bipolar disorder: a primer for primary care physicians","volume":"1","author":"Leo","year":"1999","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2017.04.005_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.clinthera.2017.04.005_bib5","unstructured":"Hirschfeld RM, Bowden CL, Gitlin MJ, et al. Practice guideline for the treatment of patients with bipolar disorder. 2nd ed: American Psychiatric Associaiton Web site, April 2002. http:\/\/www.psychiatryonline.com\/pracGuide\/pracGuideTopic_8.aspx. Accessed March 8, 2017."},{"key":"10.1016\/j.clinthera.2017.04.005_bib6","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3390\/ph3082709","article-title":"Update on the genetic polymorphisms of drug-metabolizing enzymes in antiepileptic drug therapy","volume":"3","author":"Saruwatari","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.clinthera.2017.04.005_bib7","first-page":"546","article-title":"Comparison of Valproic acid Clearance between Epileptic Patients and Patients with Acute Mania","volume":"14","author":"Mohammadpour","year":"2011","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.clinthera.2017.04.005_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R","volume":"90","author":"Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.clinthera.2017.04.005_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2710.2003.00538.x","article-title":"Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage","volume":"29","author":"Bondareva","year":"2004","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2017.04.005_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40262-014-0212-8","article-title":"A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation","volume":"54","author":"Ding","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.04.005_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2710.2008.00885.x","article-title":"Characterization of non\u2010linear relationship between total and unbound serum concentrations of valproic acid in epileptic children","volume":"33","author":"Ueshima","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2017.04.005_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies","volume":"7","author":"Yatham","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clinthera.2017.04.005_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00228-003-0699-7","article-title":"Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients","volume":"59","author":"EL Desoky","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.04.005_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1099-081X(199907)20:5<233::AID-BDD179>3.0.CO;2-5","article-title":"Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data","volume":"20","author":"Blanco\u2010Serrano","year":"1999","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.clinthera.2017.04.005_bib15","first-page":"1576","article-title":"Population pharmacokinetic model of valproate and prediction of valproate serum concentrations in children with epilepsy","volume":"25","author":"Jiang","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.clinthera.2017.04.005_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2710.2002.00440.x","article-title":"Population pharmacokinetics of intravenous valproic acid in Korean patients","volume":"27","author":"Park","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2017.04.005_bib17","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1745-7254.2007.00704.x","article-title":"Population pharmacokinetics of valproate in Chinese children with epilepsy","volume":"28","author":"Jiang","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.clinthera.2017.04.005_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/bdd.636","article-title":"Population pharmacokinetics of valproate in Mexican children with epilepsy","volume":"29","author":"Correa","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.clinthera.2017.04.005_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/FTD.0000000000000100","article-title":"Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen","volume":"37","author":"Lin","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2017.04.005_bib20","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/j.1552-4604.1995.tb04020.x","article-title":"A model for estimating individualized valproate clearance values in children","volume":"35","author":"Botha","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.04.005_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2710.2003.00528.x","article-title":"Pharmacoepidemiologic investigation of a clonazepam\u2010valproic acid interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients","volume":"28","author":"Yukawa","year":"2003","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2017.04.005_bib22","series-title":"Applied Clinical Pharmacokinetics","author":"Bauer","year":"2014"},{"key":"10.1016\/j.clinthera.2017.04.005_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3999\/jscpt.29.489","article-title":"Population pharmacokinetic parameters of valproic acid; conventional and slow release formulation","volume":"29","author":"Takinawa","year":"1998","journal-title":"Jpn J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.04.005_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/FTD.0b013e31811f3296","article-title":"Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents","volume":"29","author":"Birnbaum","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2017.04.005_bib25","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00004583-200108000-00003","article-title":"Valproic acid and risperidone","volume":"40","author":"van Wattum","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.04.005_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/S0890-8567(09)60329-4","article-title":"Valproic acid and risperidone: Commentary","volume":"40","author":"Vitiello","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.04.005_bib27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00004583-200206000-00002","article-title":"Valproic acid and risperidone","volume":"41","author":"Bertoldo","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.04.005_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004583-200301000-00001","article-title":"Valproic acid and risperidone: a drug interaction?","volume":"42","author":"Sund","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.04.005_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00002018-200629020-00001","article-title":"Interactions between antiepileptic and antipsychotic drugs","volume":"29","author":"Besag","year":"2006","journal-title":"Drug Saf"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817302400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817302400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T23:23:46Z","timestamp":1535844226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817302400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0149291817302400"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.04.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}